The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2017

Filed:

Dec. 09, 2013
Applicant:

The Queen's University of Belfast, Belfast Antrim, GB;

Inventors:

Helen McCarthy, Belfast Antrim, GB;

Aleksey Zholobenko, Larchwood Staffordshire, GB;

Ashley Davison, Belfast Antrim, GB;

Tracy Robson, Belfast Antrim, GB;

Assignee:

The Queen's University of Belfast, Belfast Antrim, GB;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); A61K 47/48 (2006.01); A61K 31/713 (2006.01); A61K 48/00 (2006.01); A61K 33/24 (2006.01); A61K 38/44 (2006.01); A61K 33/42 (2006.01); C12N 15/113 (2010.01); C12N 15/87 (2006.01); C07K 7/08 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48246 (2013.01); A61K 31/713 (2013.01); A61K 33/24 (2013.01); A61K 33/42 (2013.01); A61K 38/44 (2013.01); A61K 47/48215 (2013.01); A61K 47/48884 (2013.01); A61K 48/0025 (2013.01); C07K 7/08 (2013.01); C07K 14/00 (2013.01); C07K 14/001 (2013.01); C12N 15/113 (2013.01); C12N 15/87 (2013.01); C07K 2319/00 (2013.01); C07K 2319/09 (2013.01); C07K 2319/10 (2013.01); C07K 2319/33 (2013.01); C12N 2310/14 (2013.01); C12N 2310/3513 (2013.01); C12N 2320/32 (2013.01); C12Y 114/13039 (2013.01);
Abstract

The present invention is directed to an amphipathic peptide and methods of using the amphipathic peptide for delivering small molecule agents to a cell. Ideally, the amphipathic cell penetrating peptide comprises less than approximately 50 amino acid residues with at least 6 arginine residues, at least 12 Alanine Residues, at least 6 leucine residues, optionally at least one cysteine residue, and at least two but no greater than three glutamic acids wherein the arginine residues are evenly distributed along the length of the peptide; and the peptide has a defined ratio of arginine to negatively charged amino acid residues and a defined ratio of hydrophilic amino acid residues to hydrophobic amino acid residues. The present invention is also directed to a nanoparticle and cell delivery system comprising the amphipathic cell penetrating peptide of the invention. The peptide, nanoparticle or cell delivery system of the invention may be used in therapy. For example, the peptide may be used as a therapeutic agent delivery system, in which the therapeutic agent may include nucleic acids or other small molecules.


Find Patent Forward Citations

Loading…